2019
The Development of Clinical Guidelines and Guidance Statements by the Clinical Guidelines Committee of the American College of Physicians: Update of Methods.
Qaseem A, Kansagara D, Lin J, Mustafa R, Wilt T, Forciea M, Crandall C, Fitterman N, Hicks L, Horwitch C, Maroto M, McLean R, Roa J, Tufte J, Vijan S. The Development of Clinical Guidelines and Guidance Statements by the Clinical Guidelines Committee of the American College of Physicians: Update of Methods. Annals Of Internal Medicine 2019, 170: 863-870. PMID: 31181568, DOI: 10.7326/m18-3290.Peer-Reviewed Original ResearchConceptsClinical Guidelines CommitteeClinical guidelinesGuidance statementsGuidelines CommitteeAmerican CollegeACP Clinical Guidelines CommitteeEvidence-based clinical guidelinesPatient comorbid conditionsValue of careComorbid conditionsPatient valuesGRADE methodsStandardized reporting formatUpdate of methodsPhysiciansFurther clarificationGuidelines
2017
Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus: A Clinical Practice Guideline Update From the American College of Physicians.
Qaseem A, Barry M, Humphrey L, Forciea M, Fitterman N, Horwitch C, Kansagara D, McLean R, Wilt T. Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus: A Clinical Practice Guideline Update From the American College of Physicians. Annals Of Internal Medicine 2017, 166: 279-290. PMID: 28055075, DOI: 10.7326/m16-1860.Peer-Reviewed Original ResearchConceptsType 2 diabetesOral pharmacologic treatmentGlycemic controlPharmacologic treatmentPatient populationAmerican CollegeSodium-glucose cotransporter 2 inhibitorsType 2Clinical Practice Guideline UpdateDipeptidyl peptidase-4 inhibitorsCotransporter 2 inhibitorsSGLT-2 inhibitorsSystolic blood pressurePeptidase-4 inhibitorsDPP-4 inhibitorsTarget patient populationTotality of evidenceACP guidelinesCerebrovascular morbidityCause mortalityOral medicationsOral therapyPharmacologic therapyBlood pressureHemoglobin A1c